| Alternative Name: | Metastatic lymph node gene 19 protein, MLN 19, Proto-oncogene Neu, Tyrosine kinase-type cell surface receptor HER2, CD340 |
| |
| Clone: | 4D5-8 (Trastuzumab) |
| |
| Host: | Human |
| |
| Isotype: | IgG1κ |
| |
| Immunogen: | A431 cells (human epidermoid carcinoma) (over)expressing EGFR. |
| |
| UniProt ID: | P04626 |
| |
| Species reactivity: | Human
|
| |
| Applications: | ELISA, Flow Cytometry, IHC
|
| |
| Purity Detail: | Protein A affinity purified. |
| |
| Formulation: | Liquid. In PBS containing 0.02% Proclin 300. |
| |
| Use/Stability: | Stable at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C. |
| |
| Handling: | Avoid freeze/thaw cycles. |
| |
| Shipping: | Blue Ice |
| |
| Short Term Storage: | +4°C |
| |
| Long Term Storage: | -20°C |
| |
| Scientific Background: | Oncogenic protein Her-2/neu (erbB-2), a member of the family of epidermal growth factor (EGF) receptors, overexpressed in 30% of invasive breast cancers and 70% of ductal carcinomata in situ, in a small percentage of melanomas, and in other malignancies originating from various organs, including ovary, kidney, colon, and bladder. |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
